People: Bristol-Myers Squibb Co (BMY)
26 Jul 2017
Dr. Vicki L. Sato, Ph.D., is Independent Director of Bristol-Myers Squibb Company. She has served as a professor of management practice at the Harvard Business School since July 2005. From July 2005 to October 2014 she served as professor of the practice of molecular and cell biology at Harvard University. In 2005, Dr. Sato retired as President of Vertex Pharmaceuticals Incorporated, a global biotechnology company, where she was responsible for research and development, business and corporate development, commercial operations, legal and finance. Dr. Sato also served as Chief Scientific Officer, Senior Vice President of Research and Development and Chair of the Scientific Advisory Board at Vertex before being named President in 2000. She serves as Chairman of Denali Therapeutics, Inc. and VIR Biotechnology, Inc. and a Director of Syros Pharmaceuticals. She is a co-Chair on the Advisory Council for LifeSci NYC. She also serves on the Board of Directors of the Peer Health Exchange, Inc. Dr. Sato will not stand for re-election to the Board of Directors of PerkinElmer at their 2017 annual meeting.
|Total Annual Compensation, USD||140,000|
|Restricted Stock Awards, USD||170,000|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||25,000|
|Fiscal Year Total, USD||335,000|